Holen Sie sich die Stockscreener-App
22.36
7.53%
-1.82
Handel nachbörslich:
22.48
0.12
+0.54%
Moderna Inc Aktie (MRNA) Neueste Nachrichten
Walmart, Intuit, The Gap, SanDisk And Moderna: Why These 5 Stocks Are On Investors' Radars Today - Benzinga
Health Care Down, But not by Much, Amid Deal Activity -- Health Care Roundup - MarketScreener
IR Insights: Recapping Our 2025 Analyst Day - Moderna
Moderna Secures $1.5B Credit Facility As It Seeks To Pivot Away From Vaccines - Stocktwits
Moderna stock hits 52-week low at 23.04 USD - Investing.com India
Moderna stock hits 52-week low at 23.04 USD By Investing.com - Investing.com Canada
Moderna projects 10% growth next year; lifts outlook for year-end liquidity - MSN
Moderna secures $1.5B lifeline as it looks to break even in 2028 - BioPharma Dive
Moderna promises pipeline progress and healthy growth - The Pharma Letter
Moderna (MRNA) Unveils Pipeline Progress and Strategic Updates a - GuruFocus
Moderna gets breathing room with $1.5 billion loan from Ares - The Boston Globe
Moderna to onshore drug product manufacturing to Massachusetts - Yahoo Finance
Moderna Trims Pipeline and Takes On $1.5 Billion Loan as Cash Worries Loom - Barron's
Moderna : Presentation (Moderna 2025 Analyst Day FINAL PDF 48 ) - MarketScreener
Moderna takes $1.5 billion loan, expects 10% revenue growth next year - The Mighty 790 KFGO
Moderna (MRNA) Developments: Vaccine Approvals and Strategic Adjustments - GuruFocus
Moderna (MRNA) Projects Revenue Growth and Strategic Investments - GuruFocus
Moderna (MRNA) Reveals Strategic Plans for Growth and Innovation - GuruFocus
Moderna (MRNA) Targets Major Vaccine Expansion by 2028 - GuruFocus
Moderna (MRNA) Optimizes Global Manufacturing for Future Growth - GuruFocus
Moderna secures $1.5 billion credit facility from Ares Management By Investing.com - Investing.com Australia
Moderna secures $1.5 bln loan, targets up to 10% rev growth in 2026 - MarketScreener
Moderna outlines growth strategy targeting 10% revenue increase in 2026 - Investing.com
Moderna (MRNA) Secures $1.5 Billion Loan to Boost Financial Flex - GuruFocus
Moderna projects 10% growth next year (MRNA:NASDAQ) - Seeking Alpha
Moderna (MRNA) Unveils Strategic Growth Plans and Pipeline Updates - GuruFocus
Moderna (MRNA) Secures $1.5 Billion Loan to Enhance Financial Fl - GuruFocus
Moderna Announces Pipeline Progress and Strategy Update - TipRanks
Moderna, Inc. Announces Pipeline and Strategy Updates at Analyst Day - TradingView
Moderna Bets Big On The Future With New $1.5 Billion Loan - Finimize
Moderna Gets Breathing Room With $1.5 Billion Loan From Ares - Bloomberg.com
Moderna Analyst Day Highlights Pipeline Progress and Business Strategy Updates - ACCESS Newswire
Moderna stock rises after outlining growth strategy targeting 10% revenue growth by 2026 - Investing.com Canada
Cambridge-based Moderna lands $1.5B loan, unveils growth plans - NBC Boston
Moderna secures $1.5B loan, eyes cash breakeven in 2028 - The Business Journals
Is Moderna Inc. stock trading near support levelsSwing Trade & Trade Opportunity Analysis - newser.com
PNC Financial Services Group Inc. Has $1.56 Million Holdings in Moderna, Inc. $MRNA - MarketBeat
Can Moderna Inc. stock hit record highs again2025 Year in Review & Risk Managed Investment Entry Signals - newser.com
Arbutus Reports Major Advances in HBV Candidate as Litigation Against Moderna, Pfizer Builds Toward Trial - MyChesCo
Moderna Will Talk to Analysts on Thursday. It Needs to Stop Burning Through Cash. - Barron's
Moderna to complete US mRNA manufacturing network with $140 million investment - Reuters
Moderna to onshore drug production at Norwood facility as part of $140M expansion - The Business Journals
Moderna (MRNA) Expands U.S. Manufacturing with $140M Investment - GuruFocus
Moderna completes end-to-end mRNA manufacturing network in U.S. - Seeking Alpha
Moderna (MRNA) Expands U.S. Manufacturing with New Facility - GuruFocus
Moderna expands US manufacturing with new drug product facility By Investing.com - Investing.com Australia
Moderna expands US manufacturing with onshoring of drug product capabilities - MarketScreener
Moderna expands US manufacturing with new drug product facility - Investing.com
Moderna Expands U.S. Manufacturing with Onshoring of Drug Product Capabilities - ACCESS Newswire
Moderna (NASDAQ: MRNA) Onshores Product to Complete U.S. mRNA Manufacturing - Stock Titan
KBC Group NV Trims Stock Position in Moderna, Inc. $MRNA - MarketBeat
Moderna Inc. recovery potential after sell offTrade Risk Report & Daily Stock Trend Reports - newser.com
Moderna Brings Back Drug Product Manufacturing To Home Ground - Stocktwits
Geode Capital Management LLC Buys 1,420,690 Shares of Moderna, Inc. $MRNA - MarketBeat
Moderna to Present at Upcoming Piper Sandler's 37th Annual Healthcare Conference on December 2, 2025 - The Joplin Globe
Is Moderna Inc. stock in correction or buying zonePortfolio Gains Report & Fast Entry Momentum Trade Alerts - newser.com
Moderna, Inc. $MRNA Stock Position Lifted by Letko Brosseau & Associates Inc. - MarketBeat
SG Americas Securities LLC Purchases 487,734 Shares of Moderna, Inc. $MRNA - MarketBeat
Berenberg Adjusts Price Target on Moderna to $28 From $30, Maintains Hold Rating - MarketScreener
Financial Gravity Companies Inc. Takes Position in Moderna, Inc. $MRNA - MarketBeat
Candriam S.C.A. Decreases Stock Position in Moderna, Inc. $MRNA - MarketBeat
Moderna, Inc. $MRNA Shares Sold by Aviva PLC - MarketBeat
0.67%
0.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):